Mergers & Acquisitions Mergers & Acquisitions

Illumina-Grail deal ‘met conditions’ for EU referral, Norway says

By Natalie McNelis
  • 09 Apr 2021 10:40
  • 31 May 2021 05:48
Illumina’s bid to take over cancer-testing company Grail met the conditions for referral to the EU merger regulator, Norway says.

The Norwegian competition authority confirmed to MLex that it had joined the French competition authority's request for the Illumina-Grail deal to be referred to the European Commission (see here). 

It says that it is “of

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News